Reviva Pharmaceuticals Hldg Inc
(RVPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 11-2020 | 09-2020 | 08-2020 | 06-2020 | 05-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,020 | -2,260 | -672 | -1,600 | -156 |
| Depreciation Amortization | N/A | 1 | N/A | 0 | N/A |
| Accounts payable and accrued liabilities | 560 | 1,237 | N/A | 506 | N/A |
| Other Working Capital | 622 | 1,684 | 484 | 1,185 | 230 |
| Other Operating Activity | -683 | -1,792 | -119 | -506 | -109 |
| Operating Cash Flow | $-521 | $-1,131 | $-307 | $-415 | $-36 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | -737 | N/A | -422 | N/A | -211 |
| Other Investing Activity | 27,093 | 0 | 26,984 | 0 | 26,984 |
| Investing Cash Flow | $26,356 | $N/A | $26,562 | $N/A | $26,773 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,225 | 1,060 | 675 | 610 | 375 |
| Common Stock Issued | N/A | 424 | N/A | N/A | N/A |
| Common Stock Repurchased | -27,093 | N/A | -26,984 | N/A | -26,984 |
| Financing Cash Flow | $-25,868 | $1,484 | $-26,309 | $610 | $-26,609 |
| Beginning Cash Position | 69 | 0 | 69 | 0 | 69 |
| End Cash Position | 37 | 353 | 16 | 195 | 198 |
| Net Cash Flow | $-33 | $353 | $-54 | $195 | $129 |
| Free Cash Flow | |||||
| Operating Cash Flow | -521 | -1,131 | -307 | -415 | -36 |
| Free Cash Flow | -521 | -1,131 | -307 | -415 | -36 |